Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems
Additional integration option designed to further expand Volcano's FFR console installed base and improve procedural ease of use
|
|
FloWireฎ Doppler
Guide Wire |
|
March 12, 2010 -- San
Diego -- Volcano Corporation (Nasdaq: VOLC), a leading developer and
manufacturer of precision intravascular therapy guidance tools
designed to enhance the diagnosis and treatment of coronary and
peripheral vascular disease, announced today its Fractional Flow
Reserve (FFR) technology can now integrate with the FFR modules
of hemodynamic monitoring systems from GE, Siemens, McKesson,
and Mennen. |
"Utilization of Volcano's physiology (functional measurement) products has grown 79% in the last year, driven primarily by the landmark FAME data and recent elevation of the level of evidence for FFR in the ACC/AHA/SCAI PCI Guidelines to Level A," commented Scott Huennekens, President and CEO of Volcano. "The
FAME study demonstrated a 34% reduction in death and myocardial
infarction (MI), and a more than $2,000 reduction in costs for
patients guided by FFR instead of angiography alone. This data
has helped us place more than 1,200 FFR-capable consoles in the
last 12 months, and further integration with hemodynamic systems
will provide physicians and patients with more access to this proven
technology."
Volcano's Smart Map® Pressure Instrument and PrimeWire® Pressure
Guide Wire are now compatible with the majority of hemodynamic monitoring systems,
making the benefits of FFR accessible to more clinicians and patients. Volcano's
SmartMap will provide a pressure reading to GE Healthcare's Mac-Lab® XT and
XTi hemodynamic recording systems version 6.8.1, Siemens' AXIOM Sensis XP VC11,
McKesson's Horizon Cardiology™ Hemo version 12.1, and Mennen's Horizon
XVu Hemodynamic Monitoring System. With the pressure measurement derived from
Volcano's
PrimeWire®, hemodynamic monitoring systems have the ability to calculate
the FFR gradient and display the FFR measurement on the hemodynamic screen
in the cath lab. Volcano offers the broadest physiology product portfolio in the market today. Volcano's s5i system, the only multi-modality system on the market, offers clinicians a choice of five modalities for assessment of lesion morphology and severity on a single platform: digital IVUS for fast plug and play imaging, high-frequency rotational IVUS for higher resolution, VH® IVUS for plaque characterization, ChromaFlo® for imaging blood flow, and FFR for physiological lesion assessment.
"Our message at Volcano is quite simple," added Mr. Huennekens. "Angiography
alone is not enough, and tools such as FFR and IVUS are designed to better
assess the therapeutic strategy and result. We don't favor one technology
over another, but rather provide choice to physicians, as we are the only
company that offers both FFR and IVUS. This level of integration with hemodynamic
monitoring systems provides yet another example of choice for our customers.
If you want full function, FFR, IVUS and VH™ IVUS integration, we offer
the s5i multi-modality integrated console. If you want to start your integration
path with FFR alone, then we offer the SmartMap® Pressure instrument that
is now compatible with numerous hemodynamic system models. We provide the
choice that is right for each individual lab, and then focus our efforts
on training and educating our customers to take full advantage of an integrated
lab workflow."
About Volcano Corporation
Volcano Corporation offers a broad suite of devices
designed to facilitate endovascular procedures, enhance the diagnosis of vascular
and structural heart disease and guide optimal therapies. The company's intravascular
ultrasound (IVUS) product line includes ultrasound consoles that can be integrated
directly into virtually any modern cath lab. Volcano IVUS offers unique features,
including both single-use digital and rotational IVUS imaging catheters, and
advanced functionality options, such as VH® IVUS tissue characterization
and ChromaFlo®. Volcano also provides functional measurement (FM) consoles
and single-use pressure and flow guide wires and is developing a line of ultra-high
resolution Optical Coherence Tomography (OCT) systems and catheters. Currently,
more than 5,000 Volcano IVUS and FM systems are installed worldwide, with approximately
half of its revenues coming from outside the United States. Volcano's wholly-owned
subsidiary, Axsun Technologies, develops and manufactures optical monitors,
lasers and optical engines used in telecommunications, medical imaging, spectroscopy
and other industrial applications. For more information, visit the company's
website at www.volcanocorp.com.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the U.S. Private Securities Litigation Reform
Act of 1995. Any statements in this release regarding Volcano's business that
are not historical facts may be considered "forward-looking statements," including
statements regarding the potential benefits of the products and procedures
described above, results and implications of the data from the FAME trial,
commercial release and market adoption of the company's technology, and the
impact of clinical and other technical data. Forward-looking statements are
based on management's current preliminary expectations and are subject to risks
and uncertainties which may cause Volcano's results to differ materially and
adversely from the statements contained herein. Some of the potential risks
and uncertainties that could cause actual results to differ from the results
predicted are detailed in the company's annual report on Form 10-K and other
filings made with the Securities and Exchange Commission. Undue reliance should
not be placed on forward-looking statements which speak only as of the date
they are made. Volcano undertakes no obligation to update any forward-looking
statements to reflect new information, events or circumstances after the date
they are made, or to reflect the occurrence of unanticipated events.
Source: Volcano
Corporation
|